Diverse potential of beta-lactamase inhibitors to induce class I enzymes.

AUTOR(ES)

Weber, D A

RESUMO

The ability of various beta-lactamase inhibitors to induce class I beta-lactamases was assessed. Clavulanate was the most active compound, inducing Morganella morganii, Aeromonas caviae, and Enterobacter aerogenes over a broad concentration range and Citrobacter freundii, Pseudomonas aeruginosa, and Serratia marcescens at high concentrations. Disk approximation tests paralleled these results, with clavulanate, but not sulbactam or tazobactam, antagonizing the activity of several beta-lactams against these organisms.

Documentos Relacionados

• Influence of beta-lactamase inhibitors on the potency of their companion drug with organisms possessing class I enzymes.
• Beta-lactamase inhibitors from laboratory to clinic.
• Emergence of clinical isolates of Escherichia coli producing TEM-1 derivatives or an OXA-1 beta-lactamase conferring resistance to beta-lactamase inhibitors.
• Heterogeneity of class I beta-lactamase expression in clinical isolates of Pseudomonas aeruginosa.
• Correlation of the effect of beta-lactamase inhibitors on the beta-lactamase in growing cultures of gram-negative bacteria with their effect on the isolated beta-lactamase.